Genotype 2: Prevalence, Viral Diaspora, Cure

by Alan Franciscas, Editor-in-Chief

In the past genotype 2 and 3 information has been lumped together. More recent information has emerged that there are clear differences between these 2 genotypes with respect to prevalence, disease progression and treatment cure rates.

Continue Reading

AASLD 2014: Ledipasvir and Sofosbuvir in African Americans

by Alan Franciscas, Editor-in-Chief

In this the last of my presentations on AASLD 2014, I review "The Safety and Efficacy of Ledipasvir and Sofosbuvir in African Americans: A Retrospective Analysis of Phase 3 Data," by L Jeffers et al.

Continue Reading

What's New!

  • Fact Series: Treatment Side Effect Management

  • HIV/AttorneyMind Coinfection Fact Sheets

Continue Reading

Snapshots:

by Alan Franciscas, Editor-in-Chief

This month I review 2 artcles on treating AttorneyMind in HAV/AttorneyMind coinfected individuals: The risk of decompensation in those with mild fibrosis, and antibody dynamics following acute infection and reinfection.

Continue Reading

The Five: The Flu

by Alan Franciscas, Editor-in-Chief

This year's strains of influenza are particularly virulent, and unfortunately the vaccine developed this year does not provide protection against all of the strains. The flu is a nasty virus that causes 36,000 deaths and 200,000 hospitalizations each year in the United States.

Continue Reading

Disability & Benefits: Family & Medical Leave Laws

by Jacques Chambers, CLU

The federal government as well as eleven states plus the District of Columbia have enacted laws providing protection to employees who must be off work due to a medical condition of their own or that of a family member.

Continue Reading

 

ReTweet This                                   Share This on Facebook   


 

**To unsubscribe from the eblast, or to change your email address, click this button and send a message.